The platform, called TrumpRx, launched with 43 medications. It offers coupons or directs buyers to drugmakers' own websites ...

Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its ...

Learn about TrumpRx, a new website set to reduce prescription drug prices for millions of Americans starting in 2026.

Eli Lilly and Novo Nordisk may want to enjoy their duopoly while they can.

LONDON, Feb. 5, 2026 /PRNewswire/ -- BioPhorum, the pharmaceutical industry's most trusted collaborative network for change, ...

According to the American Cancer Society, over two million Americans will be diagnosed with cancer in 2026. Dr. Jen Caudle, a ...

Pfizer on Tuesday released trial data on a high-profile obesity drug from its recent $10 billion Metsera purchase that raises ...

Pfizer said on Tuesday its experimental obesity drug, which it acquired through the Metsera deal, showed up to 12.3% weight ...

Centers for ‌Medicare & Medicaid Services ‌on Tuesday named a new group of ⁠branded ‌drugs from major pharmaceutical ...

Pfizer Inc. enters 2026 facing earnings pressure from COVID revenue collapse and acquisition-related dilution, despite an aggressive strategic repositioning. The $10 billion Metsera acquisition ...

Pfizer's stock soared during the coronavirus pandemic because of its COVID-19 vaccine. The world has learned to live with the coronavirus, and Pfizer's stock has plunged as a result. Faced with patent ...

Pfizer stock has been a weak performer, declining by about 7% through 2025. Things could remain mixed over 2026 as well, with the company guiding for revenues of $59.5-$62.5 billion and adjusted EPS ...